CH EPL (R5)
1.0.0-ballot - ballot
This page is part of the CH EPL (R5) (v1.0.0-ballot: DSTU 1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions
Generated Narrative: RegulatedAuthorization FOPH-17418
CH - EPL Reimbursement SL
- FOPHDossierNumber: FOPH Dossier Number/17418
- status: Reimbursed
- statusDate: 2000-04-15
- listingStatus: Listed
- listingPeriod: 2000-04-15 --> (ongoing)
- firstListingDate: 2000-04-15
- costShare: 10
- gamme: Transdermal
CH - EPL Product Price
- value: CHF32.44 (CHF)
- type: Ex-factory price
- changeType: Price mutation after triennal review of pharmaceuticals
- changeDate: 2014-11-01
CH - EPL Product Price
- value: CHF53.65 (CHF)
- type: Retail price
- changeType: VAT-change
- changeDate: 2024-01-01
type: Reimbursement SL
| Extension | Reference |
| ClinicalUseDefinition: type = indication |
holder: Organization Sandoz Pharmaceuticals AG
Generated Narrative: Organization #holder-Sandoz-Pharmaceuticals-AG
Profile: CH EPL Organization
identifier: LOC Identifier/100054743, GLN Identifier/7601001029439
name: Sandoz Pharmaceuticals AG